Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGB for Vasomotor Symptoms in Breast Cancer
NCT02513329Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jul 2015
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in vasomotor symptoms, sponsored by Northwestern University. Started Jul 2015; status: completed.
02
Drugs
bupivacaine
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT02513329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513329.